Looking for a naltrexone? Not a problem!
Guaranteed Worldwide Shipping
24/7/365 Customer Support
100% Satisfaction Guaranteed.
The FDA announced the approval of the new weight loss drug on Sept. 11, 2014. The drug name is Contrave.
Using two separate drugs to lose weight can be very effective you’ll find combinations in front of the FDA now awaiting approval. When dealing with weight loss and the individuals who go through it you need to err on the side of caution and permit the FDA do its job and demand some investigation be done so the public recognizes the side effects and risks of the medications before we bring them. Keep in mind that drug companies have been in business to generate income and that they would say everything to keep people on their own medications.
Researchers found that participants using this drug for a year, dropped excess weight within 4 weeks and have kept the extra weight off through the 56 weeks in the study. Contrave can be a combination in the drugs naltrexone and bupropion, which usually reflect a new trend of weight-loss drugs that are made up of more than one active ingredient, which might make them more potent and safer.
Combo-pilling may be the newest fad or better yet the newest into the future under scrutiny and so it is just more publicly known although in the past, comb-pilling for weight loss has been around since the eighties. The biggest reason that by using a combination of pills is starting to become popular will be the fact that by right now there are not any long term prescription slimming capsules that have been approved by the FDA aside from orlistat. The truly disturbing part is always that doctors are prescribing these combinations of medications and some of the combinations are already rejected or have yet to be approved by the FDA.
Seizures are a side effect with Contrave and really should not be taken in those with seizure disorders. The drug could also raise blood pressure and pulse rate, and must not be used in individuals with a history of cardiac event or stroke in the last six months. Blood pressure and pulse should also be measured before beginning the drug and throughout therapy while using drug.
The FDA also warned that Contrave can raise blood pressure level and heart rate and must not used in patients with uncontrolled high blood pressure levels, in addition to by anyone with heart-related and cerebrovascular (circulation dysfunction impacting the mind) disease. Patients which has a history of heart attack or stroke in the last six months, life-threatening arrhythmias, or congestive heart failure were excluded from the clinical trials. Those taking Contrave should have their heart-rate and pulse monitored regularly. In addition, because the compound includes bupropion, Contrave comes having a boxed warning to alert medical professionals and patients for the increased probability of suicidal thoughts and behaviors associated with antidepressant drugs. The warning also notes that serious neuropsychiatric events are actually reported in patients taking bupropion for quitting smoking.
Approving a drug using this many potentially lethal unwanted side effects is inconsistent with the mission statement with the FDA. The power from the drug manufacturing lobby is blatantly evident inside approval of many drugs requiring ‘post-marketing’ studies which can be clearly significant to overall drug safety inside the US.